NEW YORK (Reuters Health) – Pain from cluster headaches is substantially relieved within half an hour after dosing with 5 to 10 mg of zolmitriptan nasal spray, according…
NEW YORK (Reuters Health) – Percutaneous intervention may not be necessary for the majority of hypertensive patients with atherosclerotic renovascular disease. In a large retrospective study, researchers from…
The American College of Physicians (ACP) has issued recommendations for the treatment of erectile dysfunction (ED). ACP strongly recommends that physicians initiate therapy with an oral phosphodiesterase type…
NEW YORK (Reuters Health) – The results of a systematic review suggest that use of an ACE inhibitor reduces total mortality and the risk of nonfatal MI in…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – Patients with severe cases of novel H1N1 influenza virus infection (swine flu) are at heightened risk for chest complications, including pulmonary emboli, Michigan…
NEW YORK (Reuters Health) – Deferring percutaneous coronary intervention (PCI) and treating high-risk heart disease patients with optimal medical therapy alone does not increase the risk of death,…
NEW YORK (Reuters Health) – Treatment with the third generation bisphosphonate zoledronic acid (Zometa) may improve survival in lung cancer patients with bone metastases, Greek researchers report. Between…
NEW YORK (Reuters Health) – While minimally invasive radical prostatectomy (MIRP) offers certain advantages over open retropubic radical prostatectomy (RRP), such as a shorter hospital stay, it also…
NEW YORK (Reuters Health) – Tamoxifen therapy has been linked to an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) and now new research suggests…
